140 related articles for article (PubMed ID: 19184624)
21. Development and evaluation of a gastroretentive drug delivery system for the low-absorption-window drug celecoxib.
Ali J; Tyagi P; Ahuja A; Baboota S; Hasan S
PDA J Pharm Sci Technol; 2007; 61(2):88-96. PubMed ID: 17479716
[TBL] [Abstract][Full Text] [Related]
22. Relationship between the solution thermodynamic properties of naproxen in organic solvents and its release profiles from PLGA microspheres.
Aragón DM; Rosas JE; Martínez F
J Microencapsul; 2013; 30(3):218-24. PubMed ID: 23369165
[TBL] [Abstract][Full Text] [Related]
23. Preparation of Eudragit E100 microspheres by modified solvent evaporation method.
Singh V; Chaudhary AK
Acta Pol Pharm; 2011; 68(6):975-80. PubMed ID: 22125964
[TBL] [Abstract][Full Text] [Related]
24. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
25. Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method.
Obeidat WM; Price JC
J Microencapsul; 2006 Mar; 23(2):195-202. PubMed ID: 16754375
[TBL] [Abstract][Full Text] [Related]
26. Naproxen incorporated lipid emulsions. I. Formulation and stability studies.
Nasirideen S; Kaş HS; Oner F; Alpar R; Hincal AA
J Clin Pharm Ther; 1998 Feb; 23(1):57-65. PubMed ID: 9756113
[TBL] [Abstract][Full Text] [Related]
27. Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.
Chawla A; Sharma P; Pawar P
Acta Pharm; 2012 Dec; 62(4):529-45. PubMed ID: 23333888
[TBL] [Abstract][Full Text] [Related]
28. Formulation of two-drug controlled release non-biodegradable microparticles for potential treatment of muscles pain and spasm and their simultaneous spectrophotometeric estimation.
Khan SA; Ahmad M; Murtaza G; Aamir MN; Akhtar N; Kousar R
Acta Pol Pharm; 2010; 67(3):299-306. PubMed ID: 20524433
[TBL] [Abstract][Full Text] [Related]
29. Development of enteric submicron particle formulation of papain for oral delivery.
Sharma M; Sharma V; Panda AK; Majumdar DK
Int J Nanomedicine; 2011; 6():2097-111. PubMed ID: 22114474
[TBL] [Abstract][Full Text] [Related]
30. Miconazole Nitrate-loaded Microparticles For Buccal Use: Immediate Drug Release and Antifungal Effect.
Cartagena AF; Lyra AM; Kapuchczinski AC; Urban AM; Esmerino LA; Klein T; Nadal JM; Farago PV; Campanha NH
Curr Drug Deliv; 2017; 14(8):1144-1153. PubMed ID: 27719632
[TBL] [Abstract][Full Text] [Related]
31. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
32. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.
Sawant KP; Fule R; Maniruzzaman M; Amin PD
Drug Deliv Transl Res; 2018 Dec; 8(6):1679-1693. PubMed ID: 29948916
[TBL] [Abstract][Full Text] [Related]
33. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles.
Nilkumhang S; Basit AW
Int J Pharm; 2009 Jul; 377(1-2):135-41. PubMed ID: 19515519
[TBL] [Abstract][Full Text] [Related]
34. Effect of Aerosil on the properties of lipid controlled release microparticles.
Albertini B; Passerini N; González-Rodríguez ML; Perissutti B; Rodriguez L
J Control Release; 2004 Nov; 100(2):233-46. PubMed ID: 15544871
[TBL] [Abstract][Full Text] [Related]
35. An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen.
Calija B; Cekić N; Savić S; Krajišnik D; Daniels R; Milić J
Arch Pharm Res; 2011 Jun; 34(6):919-29. PubMed ID: 21725813
[TBL] [Abstract][Full Text] [Related]
36. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE.
Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA
Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261
[TBL] [Abstract][Full Text] [Related]
37. Risk assessment of premature drug release during wet granulation of ordered mesoporous silica loaded with poorly soluble compounds itraconazole, fenofibrate, naproxen, and ibuprofen.
Vialpando M; Backhuijs F; Martens JA; Van den Mooter G
Eur J Pharm Biopharm; 2012 May; 81(1):190-8. PubMed ID: 22306694
[TBL] [Abstract][Full Text] [Related]
38. Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.
Ferreira IS; Bettencourt A; Bétrisey B; Gonçalves LM; Trampuz A; Almeida AJ
Int J Pharm; 2015 May; 485(1-2):171-82. PubMed ID: 25772414
[TBL] [Abstract][Full Text] [Related]
39. Novel Pullulan-Eudragit® S100 blend microparticles for oral delivery of risedronate: formulation, in vitro evaluation and tableting of blend microparticles.
de Arce Velasquez A; Ferreira LM; Stangarlin MF; da Silva Cde B; Rolim CM; Cruz L
Mater Sci Eng C Mater Biol Appl; 2014 May; 38():212-7. PubMed ID: 24656371
[TBL] [Abstract][Full Text] [Related]
40. Microencapsulation of ibuprofen and Eudragit RS 100 by the emulsion solvent diffusion technique.
Perumal D
Int J Pharm; 2001 May; 218(1-2):1-11. PubMed ID: 11337145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
